Literature DB >> 6775543

Influence of CO2 on cardiovascular response to hypoxia in conscious dogs.

R C Koehler, B W McDonald, J A Krasney.   

Abstract

The modulating effect of CO2 on the circulatory response to hypoxia in chronically instrumented conscious dogs was examined over a wide range of arterial partial pressure of O2 [PaO2 (from 80 to 25 Torr)] during a 41-min rebreathing period at three CO2 levels: hypocapnia (from PaCO2 of 32 to 18 Torr), eucapnia (32 Torr), and mild hypercapnia (40 Torr). Eucapnic and hypercapnic hypoxic responses were also measured after sinoaortic denervation (SAD) to assess the arterial chemoreceptor and baroreceptor reflex contributions. Elevating PaCO2 attenuated the tachycardia during hypoxia and produced progressively greater systemic, renal, and splanchnic vasoconstriction before but not after SAD. Vagal block converted the rises in renal and splanchnic flows observed during hypocapnic hypoxia to declines. The increase in left ventricular dP/dtmax was not affected by varying PaCO2 either before or after SAD. Coronary flow increased an additional onefold during hypoxia when PaCO2 was elevated both before and after SAD, but the tension-time indices did not differ significantly. These results indicate that: a) cardiopulmonary vagal afferents effectively counteract chemoreflex-induced vasoconstriction during hypocapnic hypoxia; b) chemoreflex vasoconstriction predominates in the renal and splanchnic beds when PaCO2 is elevated; c) the sinoaortic reflexes restrain the heart rate, but not the contractility response to hypoxia when PaCO2 is increased; and d) the augmented coronary vasodilation produced by CO2 is probably mediated by local CO2-hypoxic interactions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775543     DOI: 10.1152/ajpheart.1980.239.4.H545

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Effects of systemic hypoxia on the distribution of cardiac output in the rat.

Authors:  J M Marshall; J D Metcalfe
Journal:  J Physiol       Date:  1990-07       Impact factor: 5.182

2.  Serotonin nerve terminals in the dorsomedial medulla facilitate sympathetic and ventilatory responses to hemorrhage and peripheral chemoreflex activation.

Authors:  Ling-Hsuan Kung; Karie E Scrogin
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 3.  An integrative model of respiratory and cardiovascular control in sleep-disordered breathing.

Authors:  Limei Cheng; Olga Ivanova; Hsing-Hua Fan; Michael C K Khoo
Journal:  Respir Physiol Neurobiol       Date:  2010-06-11       Impact factor: 1.931

4.  Influences on the cardiovascular response to graded levels of systemic hypoxia of the accompanying hypocapnia in the rat.

Authors:  J M Marshall; J D Metcalfe
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

5.  Increased hemoglobin O2 affinity protects during acute hypoxia.

Authors:  Ozlem Yalcin; Pedro Cabrales
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

6.  Analysis of factors that contribute to cardiovascular changes induced in the cat by graded levels of systemic hypoxia.

Authors:  J M Marshall; J D Metcalfe
Journal:  J Physiol       Date:  1989-05       Impact factor: 5.182

7.  Neural effects of systemic hypoxia on hindlimb vascular resistance in sinoaortic-denervated cats.

Authors:  C V Rohlicek; T Hakim; C Polosa
Journal:  Pflugers Arch       Date:  1984-08       Impact factor: 3.657

8.  Cardiovascular changes associated with augmented breaths in normoxia and hypoxia in the rat.

Authors:  J M Marshall; J D Metcalfe
Journal:  J Physiol       Date:  1988-06       Impact factor: 5.182

9.  Vascular responses to hypercapnia in anesthetized dogs.

Authors:  K Shigemi
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

10.  Analysis of the cardiovascular changes induced in the rat by graded levels of systemic hypoxia.

Authors:  J M Marshall; J D Metcalfe
Journal:  J Physiol       Date:  1988-12       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.